![Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fleu.2017.36/MediaObjects/41375_2017_Article_BFleu201736_Fig1_HTML.jpg)
Differential signaling networks of Bcr–Abl p210 and p190 kinases in leukemia cells defined by functional proteomics | Leukemia
![Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology](https://www.frontiersin.org/files/Articles/469178/fonc-09-00863-HTML-r1/image_m/fonc-09-00863-g001.jpg)
Frontiers | Assessing Measurable Residual Disease in Chronic Myeloid Leukemia. BCR-ABL1 IS in the Avant-Garde of Molecular Hematology
![Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy | Journal of Hematology & Oncology | Full Text Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy | Journal of Hematology & Oncology | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13045-018-0624-2/MediaObjects/13045_2018_624_Fig3_HTML.png)
Past, present, and future of Bcr-Abl inhibitors: from chemical development to clinical efficacy | Journal of Hematology & Oncology | Full Text
![BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram](https://www.researchgate.net/publication/51238937/figure/fig1/AS:305846417412097@1449930876720/BCR-ABL-signaling-mimics-growth-factor-activation-Growth-factors-are-known-to-activate.png)
BCR-ABL signaling mimics growth factor activation. Growth factors are... | Download Scientific Diagram
Allosteric BCR-ABL inhibitors in Philadelphia chromosome-positive acute lymphoblastic leukemia: novel opportunities for drug combinations to overcome resistance | Haematologica
![BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia | Oncogene](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fsj.onc.1206082/MediaObjects/41388_2002_Article_BF1206082_Fig1_HTML.jpg)